{"id":"https://openalex.org/W1978484481","doi":"https://doi.org/10.1097/qad.0b013e3283315697","title":"N348I in HIV-1 reverse transcriptase decreases susceptibility to tenofovir and etravirine in combination with other resistance mutations","display_name":"N348I in HIV-1 reverse transcriptase decreases susceptibility to tenofovir and etravirine in combination with other resistance mutations","publication_year":2009,"publication_date":"2009-12-21","ids":{"openalex":"https://openalex.org/W1978484481","doi":"https://doi.org/10.1097/qad.0b013e3283315697","mag":"1978484481","pmid":"https://pubmed.ncbi.nlm.nih.gov/20010074","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/2874243"},"language":"en","primary_location":{"id":"doi:10.1097/qad.0b013e3283315697","doi":"https://doi.org/10.1097/qad.0b013e3283315697","is_oa":false,"landing_page_url":"https://doi.org/10.1097/qad.0b013e3283315697","pdf_url":null,"source":{"id":"https://openalex.org/S20605092","display_name":"AIDS","issn_l":"0269-9370","issn":["0269-9370","1473-5571"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"AIDS","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/2874243","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5044933366","display_name":"Nicolas Sluis\u2010Cremer","orcid":"https://orcid.org/0000-0003-3897-7450","observed_orcids":["https://orcid.org/0000-0003-3897-7450"]},"institutions":[{"id":"https://openalex.org/I170201317","display_name":"University of Pittsburgh","ror":"https://ror.org/01an3r305","country_code":"US","type":"education","lineage":["https://openalex.org/I170201317"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nicolas Sluis-Cremer","raw_affiliation_strings":["University of Pittsburgh School of Medicine, Department of Medicine, Pittsburgh, PA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Pittsburgh School of Medicine, Department of Medicine, Pittsburgh, PA, USA","institution_ids":["https://openalex.org/I170201317"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Katie Moore","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I145902186","display_name":"Burnet Institute","ror":"https://ror.org/05ktbsm52","country_code":"AU","type":"nonprofit","lineage":["https://openalex.org/I145902186"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Katie Moore","raw_affiliation_strings":["Molecular Interactions Group, Centre for Virology, Burnet Institute, Melbourne, Australia","Burnet Institute (Australia)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Molecular Interactions Group, Centre for Virology, Burnet Institute, Melbourne, Australia","institution_ids":["https://openalex.org/I145902186"]},{"raw_affiliation_string":"Burnet Institute (Australia)","institution_ids":["https://openalex.org/I145902186"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110089258","display_name":"Jessica Radzio","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I170201317","display_name":"University of Pittsburgh","ror":"https://ror.org/01an3r305","country_code":"US","type":"education","lineage":["https://openalex.org/I170201317"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jessica Radzio","raw_affiliation_strings":["University of Pittsburgh School of Medicine, Department of Medicine, Division of Infectious Diseases, Pittsburgh, Pennsylvania, USA","University of Pittsburgh"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Pittsburgh School of Medicine, Department of Medicine, Division of Infectious Diseases, Pittsburgh, Pennsylvania, USA","institution_ids":["https://openalex.org/I170201317"]},{"raw_affiliation_string":"University of Pittsburgh","institution_ids":["https://openalex.org/I170201317"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046491505","display_name":"Secondo Sonza","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I145902186","display_name":"Burnet Institute","ror":"https://ror.org/05ktbsm52","country_code":"AU","type":"nonprofit","lineage":["https://openalex.org/I145902186"]},{"id":"https://openalex.org/I56590836","display_name":"Monash University","ror":"https://ror.org/02bfwt286","country_code":"AU","type":"education","lineage":["https://openalex.org/I56590836"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Secondo Sonza","raw_affiliation_strings":["Department of Microbiology, Monash University, Clayton, Australia","Molecular Interactions Group, Centre for Virology, Burnet Institute, Melbourne, Australia","Microbiology"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Microbiology, Monash University, Clayton, Australia","institution_ids":["https://openalex.org/I56590836"]},{"raw_affiliation_string":"Molecular Interactions Group, Centre for Virology, Burnet Institute, Melbourne, Australia","institution_ids":["https://openalex.org/I145902186"]},{"raw_affiliation_string":"Microbiology","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5091161981","display_name":"Gilda Tachedjian","orcid":"https://orcid.org/0000-0002-7733-7037","observed_orcids":["https://orcid.org/0000-0002-7733-7037"]},"institutions":[{"id":"https://openalex.org/I145902186","display_name":"Burnet Institute","ror":"https://ror.org/05ktbsm52","country_code":"AU","type":"nonprofit","lineage":["https://openalex.org/I145902186"]},{"id":"https://openalex.org/I56590836","display_name":"Monash University","ror":"https://ror.org/02bfwt286","country_code":"AU","type":"education","lineage":["https://openalex.org/I56590836"]}],"countries":["AU"],"is_corresponding":true,"raw_author_name":"Gilda Tachedjian","raw_affiliation_strings":["Department of Medicine, Monash University, Melbourne, Victoria, Australia","Department of Microbiology, Monash University, Clayton, Australia","Molecular Interactions Group, Centre for Virology, Burnet Institute, Melbourne, Australia","to Gilda Tachedjian, PhD, Molecular Interactions Group, Centre for Virology, Burnet Institute, GPO Box 2284, Melbourne, VIC 3001, Australia. Tel: +61 3 9282 2256; fax: +61 3 9282 2100; e-mail: [email\u00a0protected]","Microbiology"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Monash University, Melbourne, Victoria, Australia","institution_ids":["https://openalex.org/I56590836"]},{"raw_affiliation_string":"Department of Microbiology, Monash University, Clayton, Australia","institution_ids":["https://openalex.org/I56590836"]},{"raw_affiliation_string":"Molecular Interactions Group, Centre for Virology, Burnet Institute, Melbourne, Australia","institution_ids":["https://openalex.org/I145902186"]},{"raw_affiliation_string":"to Gilda Tachedjian, PhD, Molecular Interactions Group, Centre for Virology, Burnet Institute, GPO Box 2284, Melbourne, VIC 3001, Australia. Tel: +61 3 9282 2256; fax: +61 3 9282 2100; e-mail: [email\u00a0protected]","institution_ids":["https://openalex.org/I145902186"]},{"raw_affiliation_string":"Microbiology","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5091161981"],"corresponding_institution_ids":["https://openalex.org/I145902186","https://openalex.org/I56590836"],"apc_list":null,"apc_paid":null,"fwci":3.2733,"has_fulltext":false,"cited_by_count":22,"citation_normalized_percentile":{"value":0.91030714,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":87,"max":97},"biblio":{"volume":"24","issue":"2","first_page":"317","last_page":"319"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10112","display_name":"HIV Research and Treatment","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2406","display_name":"Virology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10147","display_name":"Antibiotic Resistance in Bacteria","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2726","display_name":"Microbiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hiv-1-reverse-transcriptase","display_name":"HIV-1 reverse transcriptase","score":0.9959999918937683},{"id":"https://openalex.org/keywords/tenofovir-resistance","display_name":"tenofovir resistance","score":0.9670000076293945},{"id":"https://openalex.org/keywords/thymidine-analogue-mutations","display_name":"thymidine analogue mutations","score":0.8560000061988831},{"id":"https://openalex.org/keywords/y181c-mutation","display_name":"Y181C mutation","score":0.9539999961853027},{"id":"https://openalex.org/keywords/antiretroviral-drug-resistance","display_name":"antiretroviral resistance","score":0.8679999709129333}],"concepts":[{"id":"https://openalex.org/C2780345285","wikidata":"https://www.wikidata.org/wiki/Q414762","display_name":"Etravirine","level":5,"score":0.9909731149673462},{"id":"https://openalex.org/C2779130552","wikidata":"https://www.wikidata.org/wiki/Q263713","display_name":"Nevirapine","level":5,"score":0.8210622072219849},{"id":"https://openalex.org/C156719811","wikidata":"https://www.wikidata.org/wiki/Q28774","display_name":"Reverse transcriptase","level":4,"score":0.7554104328155518},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.7270787954330444},{"id":"https://openalex.org/C2780216070","wikidata":"https://www.wikidata.org/wiki/Q198504","display_name":"Zidovudine","level":4,"score":0.6751325726509094},{"id":"https://openalex.org/C2777351918","wikidata":"https://www.wikidata.org/wiki/Q421559","display_name":"Reverse-transcriptase inhibitor","level":5,"score":0.6402642726898193},{"id":"https://openalex.org/C2781432083","wikidata":"https://www.wikidata.org/wiki/Q422645","display_name":"Efavirenz","level":5,"score":0.5709762573242188},{"id":"https://openalex.org/C2779344132","wikidata":"https://www.wikidata.org/wiki/Q155954","display_name":"Tenofovir","level":3,"score":0.5691325068473816},{"id":"https://openalex.org/C3013748606","wikidata":"https://www.wikidata.org/wiki/Q15787","display_name":"Human immunodeficiency virus (HIV)","level":2,"score":0.5232164859771729},{"id":"https://openalex.org/C114851261","wikidata":"https://www.wikidata.org/wiki/Q12147416","display_name":"Drug resistance","level":2,"score":0.4592322111129761},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.380290687084198},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.337880402803421},{"id":"https://openalex.org/C2776452011","wikidata":"https://www.wikidata.org/wiki/Q311463","display_name":"Sida","level":4,"score":0.3314117193222046},{"id":"https://openalex.org/C2780727368","wikidata":"https://www.wikidata.org/wiki/Q1928978","display_name":"Viral disease","level":3,"score":0.22116926312446594},{"id":"https://openalex.org/C142462285","wikidata":"https://www.wikidata.org/wiki/Q2528140","display_name":"Viral load","level":3,"score":0.18242225050926208},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.1585659682750702},{"id":"https://openalex.org/C2993143319","wikidata":"https://www.wikidata.org/wiki/Q583050","display_name":"Antiretroviral therapy","level":4,"score":0.13803523778915405},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.08283448219299316},{"id":"https://openalex.org/C49105822","wikidata":"https://www.wikidata.org/wiki/Q176996","display_name":"Polymerase chain reaction","level":3,"score":0.06828698515892029}],"mesh":[{"descriptor_ui":"D000068698","descriptor_name":"Tenofovir","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000225","descriptor_name":"Adenine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D000225","descriptor_name":"Adenine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009154","descriptor_name":"Mutation","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D009570","descriptor_name":"Nitriles","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011724","descriptor_name":"Pyridazines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D011743","descriptor_name":"Pyrimidines","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015497","descriptor_name":"HIV-1","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D015497","descriptor_name":"HIV-1","qualifier_ui":"Q000201","qualifier_name":"enzymology","is_major_topic":false},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D016297","descriptor_name":"Mutagenesis, Site-Directed","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D018894","descriptor_name":"Reverse Transcriptase Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D024921","descriptor_name":"Drug Resistance, Multiple, Viral","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D054303","descriptor_name":"HIV Reverse Transcriptase","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D063065","descriptor_name":"Organophosphonates","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1097/qad.0b013e3283315697","doi":"https://doi.org/10.1097/qad.0b013e3283315697","is_oa":false,"landing_page_url":"https://doi.org/10.1097/qad.0b013e3283315697","pdf_url":null,"source":{"id":"https://openalex.org/S20605092","display_name":"AIDS","issn_l":"0269-9370","issn":["0269-9370","1473-5571"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"AIDS","raw_type":"journal-article"},{"id":"pmid:20010074","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/20010074","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"AIDS (London, England)","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:2874243","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/2874243","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"AIDS","raw_type":"Text"}],"best_oa_location":{"id":"pmh:oai:pubmedcentral.nih.gov:2874243","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/2874243","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"AIDS","raw_type":"Text"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.6240000128746033,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G8400168412","display_name":"Novel mechanisms of HIV resistance to RTIs","funder_award_id":"R01AI081571","funder_id":"https://openalex.org/F4320337355","funder_display_name":"National Institute of Allergy and Infectious Diseases"}],"funders":[{"id":"https://openalex.org/F4320337355","display_name":"National Institute of Allergy and Infectious Diseases","ror":"https://ror.org/043z4tv69"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":45,"referenced_works":["https://openalex.org/W69781419","https://openalex.org/W1485043351","https://openalex.org/W1586392520","https://openalex.org/W1593339216","https://openalex.org/W1659719610","https://openalex.org/W1847249683","https://openalex.org/W1970564514","https://openalex.org/W1970934635","https://openalex.org/W1972662110","https://openalex.org/W1985860622","https://openalex.org/W2008333878","https://openalex.org/W2011279174","https://openalex.org/W2026068232","https://openalex.org/W2045754079","https://openalex.org/W2048878523","https://openalex.org/W2052614354","https://openalex.org/W2053570554","https://openalex.org/W2055648403","https://openalex.org/W2056779298","https://openalex.org/W2057448926","https://openalex.org/W2061731104","https://openalex.org/W2079716870","https://openalex.org/W2087928342","https://openalex.org/W2105978365","https://openalex.org/W2115212891","https://openalex.org/W2121179908","https://openalex.org/W2125642008","https://openalex.org/W2141353064","https://openalex.org/W2148750104","https://openalex.org/W2155676461","https://openalex.org/W2163978039","https://openalex.org/W2165536523","https://openalex.org/W2169682807","https://openalex.org/W2172130850","https://openalex.org/W2182777591","https://openalex.org/W2306695044","https://openalex.org/W2316524076","https://openalex.org/W2408097419","https://openalex.org/W2414698896","https://openalex.org/W3015216974","https://openalex.org/W4236479494","https://openalex.org/W4241267536","https://openalex.org/W4297157124","https://openalex.org/W6682978103","https://openalex.org/W7043637578"],"related_works":["https://openalex.org/W6921106168","https://openalex.org/W2069320674","https://openalex.org/W2144318230","https://openalex.org/W2148784233","https://openalex.org/W2115212891","https://openalex.org/W1974701222","https://openalex.org/W7095945167","https://openalex.org/W2045696382","https://openalex.org/W2141353064","https://openalex.org/W2161771770"],"abstract_inverted_index":{"We":[0],"previously":[1],"demonstrated":[2],"that":[3,48],"N348I":[4,30,49,62],"in":[5,23],"HIV-1":[6],"reverse":[7,33],"transcriptase":[8,34],"confers":[9,51],"zidovudine":[10],"and":[11,26,39,56,73],"nevirapine":[12],"resistance.":[13],"However,":[14,61],"both":[15],"of":[16,29],"these":[17],"inhibitors":[18],"are":[19],"currently":[20],"infrequently":[21],"used":[22],"developed":[24],"countries,":[25],"the":[27],"impact":[28],"on":[31],"newer":[32],"inhibitors,":[35],"such":[36],"as":[37],"tenofovir":[38,55,65],"etravirine,":[40],"is":[41],"unknown.":[42],"In":[43],"this":[44],"study,":[45],"we":[46],"demonstrate":[47],"alone":[50],"no":[52],"resistance":[53,58],"to":[54,59],"low-level":[57],"etravirine.":[60],"significantly":[63],"decreases":[64],"susceptibility":[66,75],"when":[67,76],"combined":[68,77],"with":[69,78],"thymidine":[70],"analogue":[71],"mutations":[72],"etravirine":[74],"Y181C.":[79]},"counts_by_year":[{"year":2021,"cited_by_count":1},{"year":2017,"cited_by_count":2},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":4},{"year":2012,"cited_by_count":2}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}